- Home
- TSHA vs DENN Comparison
TSHA vs DENN Comparison
Compare TSHA & DENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- DENN
- Stock Information
- Founded
- TSHA 2019
- DENN 1953
- Country
- TSHA United States
- DENN United States
- Employees
- TSHA N/A
- DENN N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- DENN Restaurants
- Sector
- TSHA Health Care
- DENN Consumer Discretionary
- Exchange
- TSHA Nasdaq
- DENN Nasdaq
- Market Cap
- TSHA 334.1M
- DENN 329.8M
- IPO Year
- TSHA 2020
- DENN 1989
- Fundamental
- Price
- TSHA $1.61
- DENN $5.32
- Analyst Decision
- TSHA Strong Buy
- DENN Strong Buy
- Analyst Count
- TSHA 8
- DENN 6
- Target Price
- TSHA $6.63
- DENN $7.75
- AVG Volume (30 Days)
- TSHA 2.1M
- DENN 1.6M
- Earning Date
- TSHA 02-26-2025
- DENN 02-12-2025
- Dividend Yield
- TSHA N/A
- DENN N/A
- EPS Growth
- TSHA N/A
- DENN 17.14
- EPS
- TSHA N/A
- DENN 0.41
- Revenue
- TSHA $9,915,000.00
- DENN $452,334,000.00
- Revenue This Year
- TSHA N/A
- DENN $6.48
- Revenue Next Year
- TSHA N/A
- DENN $3.03
- P/E Ratio
- TSHA N/A
- DENN $12.98
- Revenue Growth
- TSHA N/A
- DENN N/A
- 52 Week Low
- TSHA $1.19
- DENN $4.83
- 52 Week High
- TSHA $4.32
- DENN $9.53
- Technical
- Relative Strength Index (RSI)
- TSHA 46.14
- DENN 41.41
- Support Level
- TSHA $1.46
- DENN $4.83
- Resistance Level
- TSHA $1.76
- DENN $7.66
- Average True Range (ATR)
- TSHA 0.15
- DENN 0.42
- MACD
- TSHA 0.01
- DENN -0.14
- Stochastic Oscillator
- TSHA 39.33
- DENN 17.31
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About DENN Denny's Corporation
Denny's Corp is one of America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees.